Legend Biotech (LEGN) News Today → Are You Positioned For The New Energy Goldrush? (From Wealthpin Pro) (Ad) Free LEGN Stock Alerts $44.87 +1.54 (+3.55%) (As of 11:21 AM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 30 at 8:13 AM | marketbeat.comArtisan Partners Limited Partnership Has $31.16 Million Position in Legend Biotech Co. (NASDAQ:LEGN)Artisan Partners Limited Partnership lessened its position in Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 7.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 517,837 shares of the cMay 29 at 8:00 AM | businesswire.comLegend Biotech to Participate in the Jefferies Global Healthcare ConferenceMay 29 at 3:24 AM | americanbankingnews.comLegend Biotech Co. (NASDAQ:LEGN) Receives Consensus Recommendation of "Buy" from AnalystsMay 29 at 3:23 AM | marketbeat.comLegend Biotech Co. (NASDAQ:LEGN) Given Consensus Recommendation of "Buy" by BrokeragesShares of Legend Biotech Co. (NASDAQ:LEGN - Get Free Report) have been assigned an average rating of "Buy" from the eleven analysts that are covering the company, MarketBeat reports. Eleven research analysts have rated the stock with a buy recommendation. The average 1-year price objective among aMay 28 at 6:29 AM | marketbeat.comTrexquant Investment LP Purchases Shares of 25,949 Legend Biotech Co. (NASDAQ:LEGN)Trexquant Investment LP purchased a new stake in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor purchased 25,949 shares of the company's stock, valued at approximatelyMay 27, 2024 | americanbankingnews.comQ4 2025 EPS Estimates for Legend Biotech Co. Decreased by Analyst (NASDAQ:LEGN)May 26, 2024 | marketbeat.comWestfield Capital Management Co. LP Purchases 108,097 Shares of Legend Biotech Co. (NASDAQ:LEGN)Westfield Capital Management Co. LP lifted its position in Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 6.5% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,776,247 shares of the coMay 26, 2024 | uk.investing.comLegend Biotech stock PT cut by H.C. Wainwright amid revenue slowdownMay 26, 2024 | americanbankingnews.comLegend Biotech (NASDAQ:LEGN) Price Target Cut to $73.00 by Analysts at HC WainwrightMay 24, 2024 | msn.comDeutsche Bank Initiates Coverage of Legend Biotech Corporation - Depositary Receipt () (LEGN) with Buy RecommendationMay 24, 2024 | americanbankingnews.comLegend Biotech (NASDAQ:LEGN) Coverage Initiated at Deutsche Bank AktiengesellschaftMay 23, 2024 | businesswire.comLegend Biotech to Highlight Leadership in CAR-T Cell Therapy for Patients with Multiple Myeloma at ASCO and EHAMay 23, 2024 | marketbeat.comLegend Biotech (NASDAQ:LEGN) Hits New 12-Month Low at $40.31Legend Biotech (NASDAQ:LEGN) Sets New 12-Month Low at $40.31May 22, 2024 | finanznachrichten.deMaxCyte, Inc: MaxCyte Signs Strategic Platform License Agreement with Legend Biotech to Accelerate Cell Therapy Discovery and DevelopmentMay 21, 2024 | marketbeat.comLegend Biotech (NASDAQ:LEGN) Trading Down 5.1%Legend Biotech (NASDAQ:LEGN) Trading Down 5.1%May 16, 2024 | marketbeat.comLegend Biotech Co. (NASDAQ:LEGN) Stock Holdings Increased by Massachusetts Financial Services Co. MAMassachusetts Financial Services Co. MA boosted its stake in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 6.3% during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 1,984,826 shares of the company's stock after purchasing aMay 15, 2024 | marketbeat.comFirst Turn Management LLC Purchases New Shares in Legend Biotech Co. (NASDAQ:LEGN)First Turn Management LLC acquired a new position in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 476,079 shares of the company's stock, valued at approximatMay 15, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Daré Bioscience (DARE), Legend Biotech (LEGN) and Singular Genomics Systems (OMIC)May 15, 2024 | msn.comLegend Biotech Corporation (NASDAQ:LEGN) Q1 2024 Earnings Call TranscriptMay 14, 2024 | markets.businessinsider.comBuy Rating for Legend Biotech Anchored by Carvykti’s Growth and Market Penetration PotentialMay 14, 2024 | marketbeat.comNicholas Investment Partners LP Trims Holdings in Legend Biotech Co. (NASDAQ:LEGN)Nicholas Investment Partners LP reduced its holdings in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 95.5% during the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 26,650 shares of the company's stock after selling 566,360 shares during the period.May 14, 2024 | markets.businessinsider.comLegend Biotech Stock: A Deep Dive Into Analyst Perspectives (14 Ratings)May 14, 2024 | marketbeat.comRoyal Bank of Canada Boosts Legend Biotech (NASDAQ:LEGN) Price Target to $86.00Royal Bank of Canada lifted their price target on shares of Legend Biotech from $85.00 to $86.00 and gave the stock an "outperform" rating in a report on Tuesday.May 14, 2024 | marketbeat.comLegend Biotech (NASDAQ:LEGN) Posts Quarterly Earnings Results, Beats Expectations By $0.13 EPSLegend Biotech (NASDAQ:LEGN - Get Free Report) issued its quarterly earnings data on Monday. The company reported ($0.16) EPS for the quarter, topping the consensus estimate of ($0.29) by $0.13. The business had revenue of $93.90 million during the quarter, compared to analyst estimates of $143.24 million. Legend Biotech had a negative net margin of 181.75% and a negative return on equity of 37.19%. The company's revenue for the quarter was up 158.7% on a year-over-year basis. During the same period in the prior year, the business earned ($0.40) EPS.May 14, 2024 | seekingalpha.comLegend Biotech's Carvykti Faces Stiff Challenges Despite AdvancesMay 14, 2024 | finance.yahoo.comLegend Biotech Corp (LEGN) Q1 2024 Earnings Call Transcript Highlights: Soaring CARVYKTI Sales ...May 14, 2024 | markets.businessinsider.comBuy Rating Affirmed for Legend Biotech on CARVYKTI Growth and Positive Clinical DevelopmentsMay 14, 2024 | finance.yahoo.comQ1 2024 Legend Biotech Corp Earnings CallMay 13, 2024 | marketbeat.comLegend Biotech (NASDAQ:LEGN) Shares Gap Up to $43.24Legend Biotech (NASDAQ:LEGN) Shares Gap Up to $43.24May 13, 2024 | marketwatch.comLegend Biotech 1Q Loss Narrows with Higher Carvykti SalesMay 13, 2024 | seekingalpha.comLegend Biotech Corporation 2024 Q1 - Results - Earnings Call PresentationMay 13, 2024 | msn.comLegend Biotech Vaults on QuarterliesMay 13, 2024 | businesswire.comLegend Biotech Reports First Quarter 2024 Results and Recent HighlightsMay 12, 2024 | marketbeat.comJump Financial LLC Buys 74,272 Shares of Legend Biotech Co. (NASDAQ:LEGN)Jump Financial LLC lifted its stake in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 157.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 121,481 shares of the company's stock after pMay 9, 2024 | marketbeat.comTimesSquare Capital Management LLC Increases Position in Legend Biotech Co. (NASDAQ:LEGN)TimesSquare Capital Management LLC lifted its stake in Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 15.4% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,065,889 shares of the company's stock after buying anMay 9, 2024 | marketbeat.comLegend Biotech's (LEGN) Buy Rating Reiterated at HC WainwrightHC Wainwright reiterated a "buy" rating and issued a $87.00 price target on shares of Legend Biotech in a report on Thursday.April 30, 2024 | marketbeat.comLegend Biotech (NASDAQ:LEGN) Sets New 52-Week Low at $43.92Legend Biotech (NASDAQ:LEGN) Sets New 12-Month Low at $43.92April 23, 2024 | marketbeat.comLegend Biotech (NASDAQ:LEGN) Receives Buy Rating from HC WainwrightHC Wainwright reissued a "buy" rating and set a $87.00 price objective on shares of Legend Biotech in a report on Tuesday.April 23, 2024 | marketbeat.comSumitomo Mitsui Trust Holdings Inc. Boosts Stake in Legend Biotech Co. (NASDAQ:LEGN)Sumitomo Mitsui Trust Holdings Inc. raised its holdings in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 15.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 163,130 shares of the company's stock afterApril 23, 2024 | markets.businessinsider.comHold Rating on Legend Biotech Amidst Approval of Carvykti and Commercial Manufacturing ChallengesApril 22, 2024 | businesswire.comCARVYKTI® (ciltacabtagene autoleucel) Approved by the European Commission for Second-line Treatment of Patients with Relapsed and Refractory Multiple MyelomaApril 22, 2024 | marketbeat.comLegend Biotech (NASDAQ:LEGN) Hits New 12-Month Low at $45.52Legend Biotech (NASDAQ:LEGN) Sets New 52-Week Low at $45.52April 20, 2024 | msn.comFDA requires labeling changes to CAR-T cell therapies to reflect cancer riskApril 20, 2024 | marketbeat.comMackenzie Financial Corp Has $9.19 Million Stock Position in Legend Biotech Co. (NASDAQ:LEGN)Mackenzie Financial Corp grew its position in Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 18.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 152,767 shares of the company's stock after buyingApril 19, 2024 | marketbeat.comFederated Hermes Inc. Decreases Position in Legend Biotech Co. (NASDAQ:LEGN)Federated Hermes Inc. trimmed its holdings in Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 2.2% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 1,725,972 shares of the company's stock after selling 38,524 shares during the quarteApril 18, 2024 | marketbeat.comQ3 2024 EPS Estimates for Legend Biotech Co. Lifted by HC Wainwright (NASDAQ:LEGN)Legend Biotech Co. (NASDAQ:LEGN - Free Report) - Equities research analysts at HC Wainwright upped their Q3 2024 earnings estimates for shares of Legend Biotech in a research note issued to investors on Tuesday, April 16th. HC Wainwright analyst M. Kapoor now forecasts that the company will earnApril 17, 2024 | seekingalpha.comScotiabank upgrades Legend Biotech to sector outperformApril 17, 2024 | marketbeat.comLegend Biotech Co. (NASDAQ:LEGN) to Post Q1 2024 Earnings of ($0.01) Per Share, HC Wainwright ForecastsLegend Biotech Co. (NASDAQ:LEGN - Free Report) - Research analysts at HC Wainwright cut their Q1 2024 earnings per share (EPS) estimates for Legend Biotech in a report released on Tuesday, April 16th. HC Wainwright analyst M. Kapoor now expects that the company will post earnings of ($0.01) per sApril 17, 2024 | marketbeat.comLegend Biotech (NASDAQ:LEGN) Raised to "Sector Outperform" at ScotiabankScotiabank raised Legend Biotech from a "sector perform" rating to a "sector outperform" rating and set a $65.00 target price for the company in a research report on Wednesday.April 17, 2024 | marketbeat.comLegend Biotech (NASDAQ:LEGN) Shares Gap Up to $50.12Legend Biotech (NASDAQ:LEGN) Shares Gap Up to $50.12 Get Legend Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for LEGN and its competitors with MarketBeat's FREE daily newsletter. Email Address Are You Positioned For The New Energy Goldrush? (Ad)Open AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has already inked deals with the Department of Energy. Click here to get all the information about it. LEGN Media Mentions By Week LEGN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LEGN News Sentiment▼0.310.82▲Average Medical News Sentiment LEGN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LEGN Articles This Week▼144▲LEGN Articles Average Week Get Legend Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for LEGN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: AUTL News BLUE News ALNY News TEVA News GMAB News RPRX News BGNE News BMRN News VTRS News UTHR News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LEGN) was last updated on 5/31/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersBill Clinton Backing Biden Replacement???The Freeport SocietyBUY ALERT: Billionaires piling into this asset classReagan Gold GroupThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarBuy this small stock before coming AI Tidal WaveChaikin Analytics41 banks launch ‘crypto dollar’Stansberry ResearchDems have chosen Biden replacement?Paradigm PressGold Set to EXPLODE!Gold Safe Exchange Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Legend Biotech Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.